Use of microarray analysis to unveil transcription factor and gene networks contributing to β cell dysfunction and apoptosis

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 55-74

  Eizirik, Decio L ^a   Kutlu, Burak ^a   Rasschaert, Joanne ^a   Darville, Martine ^a   Cardozo, Alessandra K ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Apoptosis; Chemokines; Diabetes mellitus; ER stress; Interferon ; Lnterleukin 1; MCP 1; Microarray analysis; Nitric oxide; Pancreatic beta cells

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; GAMMA INTERFERON; GLUCOSE TRANSPORTER 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PDX 1; UNINDEXED DRUG;

APOPTOSIS; B LYMPHOCYTE DIFFERENTIATION; CALCIUM HOMEOSTASIS; CELL DEATH; CELL FATE; CELL INVASION; CELL VIABILITY; CONFERENCE PAPER; CYTOKINE RELEASE; DNA MICROARRAY; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION PROFILING; HUMAN; IMMUNE MEDIATED INJURY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOLECULAR BIOLOGY; MONONUCLEAR CELL; NONHUMAN; PANCREAS ISLET BETA CELL; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 1942507406     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.007     Document Type: Conference Paper

References (99)

1. EIZIRIK, D.L. & T. MANDRUP-POULSEN. 2001. A choice of death - the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44: 2115-2133.
2. EIZIRIK, D.L. & M.I. DARVILLE. 2001. β-Cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 50(suppl. 1): S64-S69.
3. MAURICIO, D. & T. MANDRUP-POULSEN. 1998. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47: 1537-1543.
4. THOMAS, H.E. & T.W. KAY. 2001. How beta cells die in type 1 diabetes. Curr. Dir. Autoimmun. 4: 144-170.
5. MATHIS, D., L. VENCE & C. BENOIST. 2001. β-Cell death during progression to diabetes. Nature 414: 792-798.
6. LIPSHUTZ, R.J., S.P. FODOR, T.R. GINGERAS et al. 1999. High density synthetic oligonucleotide arrays. Nat. Genet. 21: 20-24.
7. CARDOZO, A.K., H. HEIMBERG, Y. HEREMANS et al. 2001. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276: 48879-48886.
8. CARDOZO, A.K., M. KRUHOFFER, R. LEEMAN et al. 2001. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50: 909-920.
9. LOCKHART, D.J. & E.A. WINZELER. 2000. Genomics, gene expression, and DNA arrays. Nature 405: 827-836.
10. YOUNG, R.A. 2000. Biomedical discovery with DNA arrays. Cell 102: 9-15.
11. LIU, D., D. PAVLOVIC, M.C. CHEN et al. 2000. Cytokines induce apoptosis in β-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes 49: 1116-1122.
12. DEL PRETE, M.J., M.S. ROBLES, A. GUAO et al. 2002. Degradation of cellular mRNA is a general early apoptosis-induced event. FASEB J. 16: 2003-2006.
13. BORG, L.A. & D.L. EIZIRIK. 1990. Short-term exposure of rat pancreatic islets to human interleukin-1βincreases cellular uptake of calcium. Immunol. Lett. 26: 253-258.
14. EIZIRIK, D.L. 1991. Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis, and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 10: 107-113.
15. DARVILLE, M.I. & D.L. EIZIRIK. 1998. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41: 1101-1108.
16. LING, Z., M. VAN DE CASTEELE, D.L. EIZIRIK et al. 2000. Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis, but not to cytokine-induced apoptosis. Diabetes 49: 340-345.
17. MCKINNON, C.M. & K. DOCHERTY. 2001. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44: 1203-1214.
18. PEDERSEN, A.A., H.V. PETERSEN, N. VIDEBAEK et al. 2002. PDX-1 mediates glucose responsiveness of GAD(67), but not GAD(65), gene transcription in islets of Langerhans. Biochem. Biophys. Res. Commun. 295: 243-248.
19. WAEBER, G., N. THOMPSON, P. NICOD et al. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10: 1327-1334.
20. BAEZA, N., A. HART, U. AHLGREN et al. 2001. Insulin promoter factor-1 controls several aspects of β-cell identity. Diabetes 50(suppl. 1): S36.
21. THOMAS, M.K., O.N. DEVON, J.H. LEE et al. 2001. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J. Clin. Invest. 108: 319-329.
22. LOTTMANN, H., J. VANSELOW, B. HESSABI et al. 2001. The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic β-cells. J. Mol. Med. 79: 321-328.
23. WELSH, N., D.L. EIZIRIK, K. BENDTZEN et al. 1991. Interleukin-1β- induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 3167-3173.
24. EIZIRIK, D.L., S. SANDLER & J.P. PALMER. 1993. Repair of pancreatic β-cells: a relevant phenomenon in early IDDM? Diabetes 42: 1383-1391.
25. AHLGREN, U., S.L. PFAFF, T.M. JESSELL et al. 1997. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385: 257-260.
26. KOJIMA, H., T. NAKAMURA, Y. FUJITA et al. 2002. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 51: 1398-1408.
27. KANETO, H., A. SHARMA, K. SUZUMA et al. 2002. Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation. J. Biol. Chem. 277: 12998-13006.
28. LAYBUTT, D.R., G.C. WEIR, H. KANETO et al. 2002. Overexpression of c-Myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 51: 1793-1804.
29. FLAMEZ, D., V. BERGER, M. KRUHOFFER et al. 2002. Critical role for cataplerosis via citrate in glucose-regulated insulin release. Diabetes 51: 2018-2024.
30. WEBB, G.C., M.S. AKBAR, C. ZHAO et al. 2000. Expression profiling of pancreatic β cells: glucose regulation of secretory and metabolic pathway genes. Proc. Natl. Acad. Sci. USA 97: 5773-5778.
31. BUSCH, A.K., D. CORDERY, G.S. DENYER et al. 2002. Expression profiling of palmitate-and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic β-cell function. Diabetes 51: 977-987.
32. LEIBOWITZ, G., M. YULI, M.Y. DONATH et al. 2001. β-Cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Diabetes 50(suppl. 1): S113-S117.
33. HOORENS, A., M. VAN DE CASTEELE, G. KLOPPEL et al. 1996. Glucose promotes survival of rat pancreatic β cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J. Clin. Invest. 98: 1568-1574.
34. CNOP, M., J.C. HANNAERT, A. HOORENS et al. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50: 1771-1777.
35. UNGER, R.H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44: 863-870.
36. MAECHLER, P. & C.B. WOLLHEIM. 2001. Mitochondrial function in normal and diabetic β-cells. Nature 414: 807-812.
37. DELANEY, C.A., D. PAVLOVIC, A. HOORENS et al. 1997. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138: 2610-2614.
38. ZUMSTEG, U., S. FRIGERIO & G.A. HOLLANDER. 2000. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β-cell damage. Diabetes 49: 39-47.
39. DARVILLE, M.I., Y.S. Ho & D.L. EIZIRIK. 2000. NF-κB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141: 153-162.
40. DARVILLE, M.I. & D.L. EIZIRIK. 2001. Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-κB and C/EBP. Diabetes 50: 1741-1748.
41. KUTLU, B., M. DARVILLE, A.K. CARDOZO et al. 2003. Molecular regulation of monocyte chemoattractant protein-1 (MCP-1) expression in pancreatic β-cells. Diabetes 52: 348-355.
42. PAVLOVIC, D., M.C. CHEN, C.A. GYSEMANS et al. 1999. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic β-cells. Eur. Cytokine Netw. 10: 403-412.
43. GYSEMANS, C.A., D. PAVLOVIC, R. BOUILLON et al. 2001. Dual role of interferon-gamma signalling pathway in sensitivity of pancreatic beta cells to immune destruction. Diabetologia 44: 567-574.
44. OYADOMARI, S., E. ARAKI & M. MORI. 2002. Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells. Apoptosis 7: 335-345.
45. VERKHRATSKY, A. & O.H. PETERSEN. 2002. The endoplasmic reticulum as an integrating signalling organelle: from neuronal signalling to neuronal death. Eur. J. Pharmacol. 447: 141-154.
46. OYADOMARI, S., K. TAKEDA, M. TAKIGUCHI et al. 2001. Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. USA 98: 10845-10850.
47. HARDING, H.P., H. ZENG, Y. ZHANG et al. 2001. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/-mice reveals a role for translational control in secretory cell survival. Mol. Cell 7: 1153-1163.
48. HARDING, H.P., Y. ZHANG & D. RON. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271-274.
49. ZHOU, Y.P., D. TENG, F. DRALYUK et al. 1998. Apoptosis in insulin-secreting cells: evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J. Clin. Invest. 101: 1623-1632.
50. LEITER, E.H. 2002. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 45: 296-308.
51. CARDOZO, A.K., P. PROOST, C. GYSEMANS et al. 2003. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46: 255-266.
52. COLVIN, B.L. & A.W. THOMSON. 2002. Chemokines, their receptors, and transplant outcome. Transplantation 74: 149-155.
53. LUSTER, A.D. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
54. CHRISTOPHERSON, K., II & R. HROMAS. 2001. Chemokine regulation of normal and pathologic immune responses. Stem Cells 19: 388-396.
55. ARIMILLI, S., W. FERLIN, N. SOLVASON et al. 2000. Chemokines in autoimmune diseases. Immunol. Rev. 177: 43-51.
56. GODESSART, N. & S.L. KUNKEL. 2001. Chemokines in autoimmune disease. Curr. Opin. Immunol. 13: 670-675.
57. SHIMADA, A., J. MORIMOTO, K. KODAMA et al. 2001. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24: 510-515.
58. HANIFI-MOGHADDAM, P., S. KAPPLER, A. ZWINDERMANN et al. 2002. Distinct cytokine and chemokine serum levels are associated with different stages of disease in diabetes mellitus type 1. Diabetes Metab. Res. Rev. 18(suppl. 4): S8.
59. NICOLETTI, F., I. CONGET, M. DI MAURO et al. 2002. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45: 1107-1110.
60. LOHMANN, T., S. LAUE, U. NIETZSCHMANN et al. 2002. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 51: 2474-2480.
61. SALLUSTO, F., C.R. MACKAY & A. LANZAVECCHIA. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
62. SALLUSTO, F., D. LENIG, C.R. MACKAY et al. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187: 875-883.
63. LOETSCHER, P., M. UGUCCIONI, L. BORDOLI et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
64. BONECCHI, R., G. BIANCHI, P.P. BORDIGNON et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J. Exp. Med. 187: 129-134.
65. CAMERON, M.J., G.A. ARREAZA, M. GRATTAN et al. 2000. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165: 1102-1110.
66. BRADLEY, L.M., V.C. ASENSIO, L.K. SCHIOETZ et al. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162: 2511-2520.
67. ABDI, R., R.N. SMITH, L. MAKHLOUF et al. 2002. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51: 2489-2495.
68. GREWAL, I.S., B.J. RUTLEDGE, J.A. FIORILLO et al. 1997. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159: 401-408.
69. PIEMONTI, L., B.E. LEONE, R. NANO et al. 2002. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51: 55-65.
70. CHEN, M.C., P. PROOST, C. GYSEMANS et al. 2001. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44: 325-332.
71. LIU, D., A.K. CARDOZO, M.I. DARVILLE et al. 2002. Double-stranded RNA cooperates with interferon-y and IL-1β to induce both chemokine expression and nuclear factor-κB-dependent apoptosis in pancreatic β-cells: potential mechanisms for viral-induced insulitis and β-cell death in type 1 diabetes mellitus. Endocrinology 143: 1225-1234.
72. SCHUTYSER, E., S. STRUYF, P. MENTEN et al. 2000. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3α from normal and transformed cells. J. Immunol. 165: 4470-4477.
73. HANENBERG, H., V. KOLB-BACHOFEN, G. KANTWERK-FUNKE et al. 1989. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32: 126-134.
74. JUN, H.S., P. SANTAMARIA, H.W. LIM et al. 1999. Absolute requirement of macrophages for the development and activation of β-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes 48: 34-42.
75. OSCHILEWSKI, U., U. KIESEL & H. KOLB. 1985. Administration of silica prevents diabetes in BB-rats. Diabetes 34: 197-199.
76. ROTHE, H., A. HAUSMANN & H. KOLB. 2002. Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15. Horm. Metab. Res. 34: 7-12.
77. YOON, J.W., H.S. JUN & P. SANTAMARIA. 1998. Cellular and molecular mechanisms for the initiation and progression of β cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27: 109-122.
78. THOMAS, H.E. & T.W. KAY. 2000. β cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab. Res. Rev. 16: 251-261.
79. CASTEELS, K., M. WAER, J. LAUREYS et al. 1998. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 65: 1225-1232.
80. SUAREZ-PINZON, W., R.V. RAJOTTE, T.R. MOSMANN et al. 1996. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction. Diabetes 45: 1350-1357.
81. GYSEMANS, C.A., M. WAER, D. VALCKX et al. 2000. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-β mRNA in the grafts. Diabetes 49: 1992-1997.
82. EIZIRIK, D.L., M. FLODSTROM, A.E. KARLSEN et al. 1996. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetologia 39: 875-890.
83. GHOSH, S., M.J. MAY & E.B. KOPP. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
84. BROWN, K., S. GERSTBERGER, L. CARLSON et al. 1995. Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
85. CHEN, L. & X. GAO. 2002. Neuronal apoptosis induced by endoplasmic reticulum stress. Neurochem. Res. 27: 891-899.
86. BARKETT, M. & T.D. GILMORE. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910-6924.
87. JOBIN, C., A. PANJA, C. HELLERBRAND et al. 1998. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells. J. Immunol. 160: 410-418.
88. HELLERBRAND, C., C. JOBIN, Y. IIMURO et al. 1998. Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology 27: 1285-1295.
89. HEIMBERG, H., Y. HEREMANS, C. JOBIN et al. 2001. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50: 2219-2224.
90. GIANNOUKAKIS, N., W.A. RUDERT, M. TRUCCO et al. 2000. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J. Biol. Chem. 275: 36509-36513.
91. BAKER, M.S., X. CHEN, X.C. CAO et al. 2001. Expression of a dominant negative inhibitor of NF-κB protects MIN6 β-cells from cytokine-induced apoptosis. J. Surg. Res. 97: 117-122.
92. EDLUND, H. 2001. Factors controlling pancreatic cell differentiation and function. Diabetologia 44: 1071-1079.
93. FERRER, J. 2002. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes 51: 2355-2362.
94. AZEVEDO-MARTINS, A.K., S. LORTZ, S. LENZEN et al. 2003. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced NF-κB activation in insulin-producing cells. Diabetes 52: 93-101.
95. NIEMANN, A., A. BJORKLUND & D.L. EIZIRIK. 1994. Studies on the molecular regulation of the inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Mol. Cell. Endocrinol. 106: 151-155.
96. MAY, M.J. & S. GHOSH. 1998. Signal transduction through NF-κB. Immunol. Today 19: 80-88.
97. TAK, P.P. & G.S. FIRESTEIN. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11.
98. LANDER, E.S., L.M. LINTON, B. BIRREN et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
99. VENTER, J.C., M.D. ADAMS, E.W. MYERS et al. 2001. The sequence of the human genome. Science 291: 1304-1351.